SAVI, Monia
 Distribuzione geografica
Continente #
NA - Nord America 4.506
AS - Asia 3.257
EU - Europa 3.197
SA - Sud America 420
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 11.518
Nazione #
US - Stati Uniti d'America 4.397
CN - Cina 1.282
SG - Singapore 1.243
IT - Italia 606
FI - Finlandia 594
IE - Irlanda 477
DE - Germania 390
SE - Svezia 390
BR - Brasile 327
HK - Hong Kong 261
UA - Ucraina 199
VN - Vietnam 197
FR - Francia 109
NL - Olanda 103
ZA - Sudafrica 92
TR - Turchia 81
CA - Canada 78
GB - Regno Unito 77
AT - Austria 55
RU - Federazione Russa 51
BE - Belgio 49
IN - India 47
BD - Bangladesh 43
AR - Argentina 35
CZ - Repubblica Ceca 21
EC - Ecuador 21
MX - Messico 21
CH - Svizzera 17
JP - Giappone 16
PL - Polonia 16
KR - Corea 15
IQ - Iraq 14
CO - Colombia 12
LT - Lituania 12
ES - Italia 11
ID - Indonesia 10
EU - Europa 8
MA - Marocco 7
VE - Venezuela 7
EG - Egitto 6
IR - Iran 6
PK - Pakistan 6
PY - Paraguay 6
SK - Slovacchia (Repubblica Slovacca) 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CI - Costa d'Avorio 5
PE - Perù 5
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
NP - Nepal 4
OM - Oman 4
AU - Australia 3
CR - Costa Rica 3
EE - Estonia 3
KE - Kenya 3
NG - Nigeria 3
RS - Serbia 3
TN - Tunisia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
PR - Porto Rico 2
QA - Qatar 2
AL - Albania 1
BH - Bahrain 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 11.518
Città #
Singapore 587
Dallas 507
Ashburn 480
Dublin 477
Chandler 434
Ann Arbor 306
Beijing 297
Santa Clara 270
Jacksonville 266
Hong Kong 254
Dearborn 248
Parma 232
Boardman 161
Nanjing 158
New York 127
Wilmington 124
Johannesburg 87
Shanghai 87
Bremen 79
Princeton 79
Hefei 74
Izmir 69
Munich 69
Helsinki 68
Seattle 64
Los Angeles 63
Jinan 61
Ho Chi Minh City 58
Padova 58
Brussels 48
Tulsa 47
Vienna 47
Nanchang 45
Shenyang 43
Kunming 40
San Mateo 39
Dong Ket 38
Toronto 37
Hanoi 36
Des Moines 35
Hebei 33
Changsha 31
Council Bluffs 28
Marseille 27
Columbus 26
São Paulo 26
The Dalles 26
Turku 26
Buffalo 24
Woodbridge 24
Falkenstein 23
Moscow 23
Tianjin 23
Houston 22
Zhengzhou 22
London 21
Guangzhou 18
Milan 18
Ningbo 18
Bologna 15
Brooklyn 15
Denver 15
Montreal 15
Ottawa 15
Seoul 15
Frankfurt am Main 14
Jiaxing 14
Tokyo 14
Warsaw 14
Boston 13
Chennai 13
Falls Church 13
Lanzhou 13
Redmond 13
Taizhou 13
Fremont 12
Nuremberg 12
Quito 12
Hangzhou 11
Belo Horizonte 10
Haikou 10
Jakarta 10
Pune 10
Rio de Janeiro 10
Baghdad 9
Brno 9
Chicago 9
Curitiba 9
Modena 9
Phoenix 9
Rome 9
Amsterdam 8
Haiphong 8
Taiyuan 8
Atlanta 7
Campinas 7
Manchester 7
Orem 7
Bratislava 6
Düsseldorf 6
Totale 7.206
Nome #
Cobalt oxide nanoparticles induce oxidative stress and alter electromechanical function in rat ventricular myocytes 394
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 240
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 235
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart 221
Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. 220
Cardiac effects of acute exposure to titanium dioxide nanoparticles: electrophysiological characterization 216
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 213
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue 212
5-(Hydroxyphenyl)-γ-Valerolactone-Sulfate, a Key Microbial Metabolite of Flavan-3-ols, Is Able to Reach the Brain: Evidence from Different in Silico, In Vitro and In Vivo Experimental Models 210
Bioaccumulation of Resveratrol Metabolites in Myocardial Tissue is Dose-Time Dependent and Related to Cardiac Hemodynamics in Diabetic Rats 201
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 200
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 194
Cardiac stem cell disease in diabetic cardiomyopathy: perspectives for preventing cardiac morpho-functional remodelling 185
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 182
Not just a witness: Highlighting the utility of witness social defeat stress for the examination of neuroimmune-cardiovascular interactions across diverse populations 181
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 180
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 176
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 173
Effects of acute exposure to titanium dioxide (TiO2) nanoparticles on ventricular cardiomyocytes: mechanical and cytotoxic characterization. 172
Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. 162
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 160
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 160
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 160
Nanoparticles exposure: In-vitro and in-vivo investigation to evaluate cardiovascu1ar risk factors in normal and failing cardiac tissue [Esposizione a nanoparticelle: Studi in-vitro ed in-vivo per valutare i fattori di rischio cardiovascolari in cuori normali e patologici] 157
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 156
Amelioration of cardiac electrical performance following stem cell based regenerative therapies, in infarcted rat heart 148
Mobilization of cardiac progenitor cells by Hepatocyte Growth Factor (HGF) and Insulin-like Growth Factor-1 (IGF-1) for repairing chronic myocardial infarction (MI) is not proarrhytmic. 147
The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice. 146
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 146
Repair of chronic myocardial infarction (MI) induced by mobilization of cardiac progenitor cells (CPCs) via local delivery of hapatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) is not proarrhythmic. 144
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 144
Development and validation of an high performance liquidchromatography–tandem mass spectrometry method for the determination of imatinib in rat tissues 143
Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide 143
Elevated miR-34a expression and altered transcriptional profile are associated with adverse electromechanical remodeling in the heart of male rats exposed to social stress 143
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 142
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 140
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 136
Hystone deacetylase inhibitors (HDACi) ameliorate cardiac elctrical competence in mdx mouse model of Duchenne muscular dystrophy (DMD). 136
Deacetylase inhibitors reduce cardiac arrhythmogenesis in mdx mouse model of duchenne muscular dystrophy (DMD). 135
Electro-mechanical competence of regenerated heart in stem cell based therapy of myocardial infarction in rat model. 131
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 131
Cardiac electromechanical performance following stem cell based regenerative therapies in infarcted rat heart. 130
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico. 129
High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts 127
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 126
Resident cardiac stem cells. 125
Stem cells and myocardial regeneration 124
Changes in actin isoform expression prior to the transition from compensated pressure-overload cardiac hypertrophy to decompensation. 123
Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions 120
Functional recovery of the infarcted heart mediated by pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors 118
High-Resolution X-Ray Microtomography for Three-Dimensional Visualization of Cardiac Progenitor Cells Homing in Infarcted Rat Hearts 118
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 117
Imatinib mesylate induced cardiotoxicity: a cardiac progenitor cell disease? 116
Studio in vitro ed in vivo della biocompatibilità di PAM (pharmacologically active microcarriers) come substrato per la rigenerazione miocardica 114
Deacetylase Inhibitors ameliorate cardiac electrical competence in MDX mouse model of Duchenne muscular dystrophy (DMD). 114
Valutazione dell’efficacia rigenerativa della mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardio 113
Phase-contrast microtomography: are the tracers necessary for stem cell tracking in infarcted hearts? 113
Electromechanical competence of the myocardium regenerated by growth factors and cell therapy in ischemic cardiomyopathy. 110
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico 110
Mobilization of cardiac progenitor cells by hepatocyte growth factor and insulin-like growth factor-1 for repairing chronic myocardial infarction is not proarrhythmic. 110
Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation. 108
Histone deacetylase inhibitors ameliorate cardiac electrical competence in dystrophic mice. 106
Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats 106
Electrical stability of infarcted rat hearts following treatment with stem cells 105
Changes in actin isoform expression are involved in the transition from compensated pressure-overload cardiac hypertrophy to ventricular dysfunction 105
Effects of the alpha2-adrenergic/DA2-dopaminergic agonist CHF-1024 in preventing ventricular arrhythmogenesis and myocyte electrical remodeling, in a rat model of pressure-overload cardiac hypertrophy 102
Alpha-skeletal actin expression correlate with the degree of pressure overload cardiac hypertrophy, preserving cardiac function. 102
Alpha-skeletal actin expression correlate with the degree of pressure overload cardiac hypertrophy, preserving cardiac function 102
Role of cardiac lymphatic vessels in ischemic and drug induced cardiomyopathy 101
Changes in actin isoform expression are involved in the transition from compensated pressure-overload cardiac hypertrophy to ventricular dysfunction 100
Early antioxidant treatment with resveratrol: a new therapeutic approach for preventing diabetic cardiomyopathy 99
Electrical competence of newly formed tissue in stem cell based regeneration of myocardial infarction in rat model 99
Electro-mechanical competence of regenerated heart in stem cell based therapy of myocardial infarction in rat model 97
Pharmacologically active microcarriers conveying human adipose-derived stem cells and/or releasing growth factors in myocardial regeneration 96
Hdac inhibition improves the sarcoendoplasmic reticulum Ca2+-ATPase activity in cardiac myocytes 96
High-resolution X-ray microtomography for three-dimensional visualization of Cardiac Progenitor Cells Homing in infarcted rat hearts. 89
Valutazione dell’efficacia rigenerativa della mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardio. 88
Stem cell based regenerative therapies in healed myocardial infarction 87
In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats 82
Uso di microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in modelli di ratto di infarto miocardico 77
Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves myocyte proliferation and changes in intercellular coupling 76
Exogenous high-mobility group box 1 protein (hmgb1) ameliorates cardiac electrical performance in infarcted rat heart 75
Electrical competence of infarcted heart following stem cell based regenerative therapy, in a rat model 74
Totale 11.644
Categoria #
all - tutte 36.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021508 0 0 0 0 0 33 85 25 190 32 85 58
2021/2022444 21 31 10 18 14 19 58 46 14 30 36 147
2022/20231.854 168 172 120 141 220 199 15 123 575 4 71 46
2023/2024811 37 66 24 13 58 252 78 54 22 53 83 71
2024/20252.236 25 101 114 213 278 255 112 117 222 173 208 418
2025/20262.660 387 691 535 389 615 43 0 0 0 0 0 0
Totale 11.644